RUBICONBSERubicon Research LtdMediumPositive
Announced Fri, 29 May · 17:55 IST

The Board of Directors at its Meeting held on 29 May 2026, approved and recommended the formulation and adoption of New Employee Benefit Plan

RUBICON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+26.8%1-day move
₹1000.00
prior close
₹1044.30
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.2+5.2+4.9+8.4+26.8+27.0+29.5+22.7+17.0+19.2+37.7+37.0
Up moveDown movePending
AI summary

Rubicon Research Limited's Board of Directors approved the formulation of a new Employees Stock Option Scheme 2026 at their meeting on May 29, 2026. The scheme authorises the grant of stock options covering up to 24,84,415 equity shares of Rs 1 each, including 6,72,162 shares from the balance pool of the earlier 2022 scheme. The exercise price will not be less than the face value of shares. The proposal is subject to approval by shareholders and other regulatory clearances. The company states the new scheme complies with SEBI's Share Based Employee Benefits Regulations, 2021.

Likely market impact

This ESOP scheme aims to attract and retain talent by offering equity-based compensation, which may help align employee and shareholder interests. However, the potential issuance of nearly 24.84 lakh shares could cause minor dilution for existing shareholders pending shareholder approval.